Avanza Fonder AB bought a new stake in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 54,809 shares of the real estate investment trust's stock, valued at approximately $960,000.
A number of other large investors have also recently modified their holdings of DOC. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Healthpeak Properties by 9.3% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 57,951 shares of the real estate investment trust's stock valued at $1,175,000 after purchasing an additional 4,920 shares in the last quarter. Woodline Partners LP purchased a new position in Healthpeak Properties during the 4th quarter valued at about $848,000. GF Fund Management CO. LTD. purchased a new position in Healthpeak Properties during the 4th quarter valued at about $258,000. Toronto Dominion Bank lifted its position in Healthpeak Properties by 32.3% during the 4th quarter. Toronto Dominion Bank now owns 463,115 shares of the real estate investment trust's stock valued at $9,387,000 after acquiring an additional 113,182 shares during the period. Finally, Mackenzie Financial Corp lifted its position in Healthpeak Properties by 229.5% during the 4th quarter. Mackenzie Financial Corp now owns 85,461 shares of the real estate investment trust's stock valued at $1,732,000 after acquiring an additional 59,524 shares during the period. Institutional investors own 93.57% of the company's stock.
Analyst Upgrades and Downgrades
DOC has been the subject of a number of recent research reports. Robert W. Baird set a $21.00 price target on shares of Healthpeak Properties and gave the company an "outperform" rating in a research report on Wednesday, July 30th. Wells Fargo & Company lowered their price target on shares of Healthpeak Properties from $20.00 to $18.00 and set an "equal weight" rating for the company in a research report on Wednesday, August 27th. Wall Street Zen cut shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a research report on Monday, July 7th. Scotiabank cut shares of Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and lowered their price target for the company from $21.00 to $19.00 in a research report on Tuesday, July 29th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and issued a $18.00 target price (down from $28.00) on shares of Healthpeak Properties in a report on Wednesday, August 20th. Eight investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, Healthpeak Properties currently has a consensus rating of "Moderate Buy" and a consensus target price of $21.45.
Read Our Latest Analysis on Healthpeak Properties
Insider Buying and Selling at Healthpeak Properties
In other news, CEO Scott M. Brinker purchased 2,930 shares of the company's stock in a transaction on Thursday, July 31st. The stock was acquired at an average cost of $17.06 per share, for a total transaction of $49,985.80. Following the completion of the transaction, the chief executive officer directly owned 210,416 shares in the company, valued at $3,589,696.96. This trade represents a 1.41% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders have purchased 8,783 shares of company stock valued at $150,129 in the last three months. Corporate insiders own 0.23% of the company's stock.
Healthpeak Properties Stock Performance
Shares of NYSE DOC opened at $18.54 on Tuesday. The firm has a 50 day moving average of $17.76 and a 200 day moving average of $18.09. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 1.06. The firm has a market capitalization of $12.88 billion, a price-to-earnings ratio of 77.23, a price-to-earnings-growth ratio of 2.38 and a beta of 1.07. Healthpeak Properties, Inc. has a 12-month low of $16.63 and a 12-month high of $23.26.
Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.46. The company had revenue of $694.35 million during the quarter, compared to analyst estimates of $697.14 million. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. The firm's quarterly revenue was down .2% compared to the same quarter last year. During the same period in the previous year, the business posted $0.45 earnings per share. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. On average, research analysts anticipate that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current year.
Healthpeak Properties Announces Dividend
The company also recently declared a monthly dividend, which was paid on Friday, August 29th. Shareholders of record on Monday, August 18th were given a $0.1017 dividend. This represents a c) dividend on an annualized basis and a dividend yield of 6.6%. The ex-dividend date was Monday, August 18th. Healthpeak Properties's dividend payout ratio is presently 508.33%.
Healthpeak Properties Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Further Reading
Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.